TRISODIUM CITRATE DIHYDRATE

Electrolyte / Mineral

Brand names: Sodium Citrate 4% w/v Anticoagulant

Intravenous

Mechanism of Action

12.1 Mechanism of Action SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP acts as an extracorporeal anticoagulant by binding the free calcium in the blood. Calcium is a necessary co-factor to several steps in the clotting cascade. The following ingredients are key components of the solution: Citric acid for pH regulation Sodium Citrate anticoagulant This solution has no pharmacological effect.

Indications

See full prescribing information

Contraindications

• 4 CONTRAINDICATIONS DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. DO NOT INFUSE SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP DIRECTLY TO THE DONOR. ( 4 )

FDA Warnings

5 WARNINGS AND PRECAUTIONS Verify that the SODIUM CITRATE 4% W/V ANTICOAGULANT SOLUTION USP has been securely attached to the Anticoagulant (AC) line on the system tubing set

Known Side Effects

7 documented side effects by frequency

Tingling/Numbness

>10%

Nausea

>10%

Dizziness

>10%

Excessive Sweating

1-10%

Weakness

0.1-1%

Blurred Vision

0.1-1%

Indigestion

0.1-1%

Community Discussions

No community discussions found for TRISODIUM CITRATE DIHYDRATE yet.

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Intravenous